A new study reveals a defective version of astrocytes may be linked to the build up of alpha synuclein and could spur Parkinson’s disease. The findings show the important role glial cells play in Parkinson’s and offers insights into new targets for therapies to fight the neurodegenerative disease.
A genome-wide analysis of nearly 45,000 people has identified 16 regions of DNA associated with epilepsy, 11 of which are newly identified.
Scientists at the Max Planck Institute for Metabolism Research in Cologne found when people crave specific foods, the brain releases more dopamine when they finally consume the item. The study reports the gastrointestinal tract is in constant contact with the brain and uses reward stimuli to control our desire for food.
Researchers have developed a method to determine the length of mutated genes associated with Huntington’s disease quickly and easily.
Men with dyslexia have altered structural connections between the thalamus and auditory cortex on the left side of the brain, new research published in Journal of Neuroscience reveals.
A new study reports when we retrieve information about visual objects, the brain first focuses on the core meaning and afterwards recalls specific details.
Researchers report that neuron loss in Alzheimer’s disease may not be such a bad thing. The study reveals the loss of neurons may be the result of a cell quality control mechanism attempting to protect the brain from the accumulation of malfunctioning neurons.
Neurofeedback training stimulates the cortical learning process and can help improve the sense of touch, a new study reveals.
Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis (ALS), a neurological disease that is extremely difficult to diagnose and treat.
Finally this week, researchers have identified over 500 genetic variants which affect the use of, and addiction to, alcohol and tobacco.